{
    "Trade/Device Name(s)": [
        "ETEST Imipenem/Relebactam P. aeruginosa (IRPA) (0.008/4-128/4 \u00b5g/mL)",
        "ETEST (IRPA)"
    ],
    "Submitter Information": "bioMerieux SA",
    "510(k) Number": "K250274",
    "Predicate Device Reference 510(k) Number(s)": [
        "K183031"
    ],
    "Regulatory Class": "Class II",
    "Product Code(s)": [
        "JWY"
    ],
    "Summary Letter Date": "January 30, 2025",
    "Summary Letter Received Date": "January 30, 2025",
    "Submission Date": "April 28, 2025",
    "Regulation Number(s)": [
        "21 CFR 866.1640"
    ],
    "Regulation Name(s)": [
        "Antimicrobial Susceptibility Test Powder",
        "Manual Antimicrobial Susceptibility Test Systems"
    ],
    "Analyte Class(es)": [
        "microbiology"
    ],
    "Analyte(s)": [
        "Imipenem",
        "Relebactam"
    ],
    "Specimen Type(s)": [
        "Agar culture isolates"
    ],
    "Specimen Container(s)": [],
    "Instrument(s)/Platform(s)": [],
    "Method(s)/Technology(ies)": [
        "Manual antimicrobial susceptibility testing",
        "Predefined antibiotic gradient strip"
    ],
    "Methodologies": [
        "Minimum Inhibitory Concentration determination",
        "Quantitative gradient diffusion"
    ],
    "Submission Type(s)": [
        "Strip test",
        "Reagent"
    ],
    "Document Summary": "FDA 510(k) summary for ETEST Imipenem/Relebactam P. aeruginosa (IRPA) strip for MIC determination in Pseudomonas aeruginosa.",
    "Indications for Use Summary": "Manual quantitative determination of antimicrobial susceptibility of Pseudomonas aeruginosa using a predefined antibiotic gradient to determine MIC on agar media.",
    "fda_folder": "Microbiology"
}